ReviewChinese medicine2026
Natural polysaccharides targeting mitochondrial function for colorectal cancer prevention and treatment: mechanisms and nano-delivery strategies.
Review in Chinese medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundColorectal cancer (CRC) is a malignant tumor of the digestive system with high incidence and mortality worldwide. Mitochondrial dysfunction plays a central role in the development, progression, and chemotherapy resistance of CRC. Natural polysaccharides have attracted increasing attention in anti-CRC research in recent years due to their wide sources, low toxicity, good biocompatibility, and multi-target activities.
objectiveTo systematically review the molecular mechanisms by which natural polysaccharides target mitochondrial dysfunction to prevent and treat CRC, and to summarize the research progress of nano-delivery strategies.
methodsA systematic search was conducted in PubMed, Web of Science, Scopus, and SinoMed databases for literature published from January 1, 2015 to June 3, 2026. A total of 89 articles were included for analysis.
resultsNatural polysaccharides exert anti-CRC effects through synergistic actions of multiple pathways, including regulation of reactive oxygen species homeostasis, induction of mitochondrial apoptosis and autophagy, remodeling of the tumor immune microenvironment, and protection of intestinal barrier function. Their bioactivities are closely related to molecular weight, monosaccharide composition, glycosidic bond type, branching structure, and chemical modification. Nano-delivery technologies can significantly improve their targeting efficiency and therapeutic activity. Regarding clinical studies, current evidence mainly focuses on the combined use of natural polysaccharides with chemotherapy and the management of cancer-related symptoms; direct clinical evidence targeting CRC resistance remains limited.
conclusionMitochondria-targeting nano-systems based on natural polysaccharides provide a promising multi-target strategy for CRC prevention, treatment, and reversal of chemotherapy resistance. However, current evidence has limitations, including inconsistent structural characterization, lack of direct co-localization evidence, and insufficient pharmacokinetic-pharmacodynamic evaluations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.